Low dose dopamine (1-2 mcg/kg) result in
Dopamine has a dose-dependent effect. At low doses (1-2 mcg/kg/min), it primarily acts on D1 receptors. These receptors are found in the renal, mesenteric, and coronary vasculature. Activation of D1 receptors causes vasodilation, which increases renal blood flow and glomerular filtration rate. This is why low-dose dopamine is sometimes used in patients with acute kidney injury to try to improve renal perfusion.
Now, the wrong options. Let's say the options were A: Beta-1 stimulation leading to increased heart rate, B: Alpha-1 stimulation causing vasoconstriction, C: D1 receptor-mediated renal vasodilation, D: Inhibition of norepinephrine reuptake.
Option A is incorrect because low-dose dopamine doesn't significantly affect beta-1 receptors. Beta-1 effects are more prominent at higher doses. Option B is wrong because alpha-1 stimulation occurs at higher doses, leading to vasoconstriction. Option D might be incorrect because dopamine's reuptake inhibition isn't the primary mechanism at low doses.
The clinical pearl here is remembering the mnemonic DAD for dopamine's effects: D (D1 receptors) for low dose, A (Alpha-1) for intermediate, and D (Dopamine release) for high dose. But wait, high-dose dopamine actually acts on beta-1 and alpha-1 receptors. Maybe the correct mnemonic is D1 at low, D1 and beta-1 at moderate, and beta-1 and alpha-1 at high. The key is that low-dose is D1-mediated renal vasodilation. Students often confuse the different receptor actions with the doses, so emphasizing the D1 receptors at low doses is important.
**Core Concept**
Dopamine exerts dose-dependent effects mediated by distinct receptor subtypes. At low doses (1-2 mcg/kg/min), it primarily activates **D1 dopamine receptors**, causing **renal and mesenteric vasodilation** via increased cyclic AMP (cAMP) in vascular smooth muscle.
**Why the Correct Answer is Right**
Low-dose dopamine (1-2 mcg/kg/min) selectively stimulates **D1 receptors** in renal afferent arterioles, reducing vascular resistance and increasing renal blood flow. This enhances glomerular filtration rate (GFR) and sodium excretion, making it a theoretical adjunct in acute kidney injury. The mechanism is distinct from beta-1 or alpha-1 adrenergic effects seen at higher doses.
**Why Each Wrong Option is Incorrect**
**Option A:** Beta-1 stimulation (increased heart rate) occurs at moderate doses (2-10 mcg/kg/min), not low doses.
**Option B:** Alpha-1 vasoconstriction dominates at high doses (>10 mcg/kg/min), opposing renal vasodilation.
**Option D:** Dopamine does not inhibit norepinephrine reuptake at any clinically relevant dose; this is a mechanism of other drugs like amphetamines.
**Clinical Pearl / High-Yield Fact**
Remember the **"Dopamine